# The Effect of Cooling on Sclerotherapy Efficacy

> **NCT04690803** · PHASE4 · UNKNOWN · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 20 (estimated)

## Conditions studied

- Leg Veins

## Interventions

- **DRUG:** air cooling

## Key facts

- **NCT ID:** NCT04690803
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-06
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04690803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04690803, "The Effect of Cooling on Sclerotherapy Efficacy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04690803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*